Luye Pharma Group Ltd. (HKG:2186)
Hong Kong
· Delayed Price · Currency is HKD 2.480
+0.020 (0.81%)
Mar 10, 2026, 1:54 PM HKT
Luye Pharma Group Revenue
Luye Pharma Group had revenue of 3.18B CNY in the half year ending June 30, 2025, with 9.54% growth. This brings the company's revenue in the last twelve months to 6.17B, down -2.31% year-over-year. In the year 2024, Luye Pharma Group had annual revenue of 6.06B, down -1.33%.
Revenue (ttm)
6.17B CNY
Revenue Growth
-2.31%
P/S Ratio
1.45
Revenue / Employee
1.21M CNY
Employees
5,115
Market Cap
9.83B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.06B | -81.64M | -1.33% |
| Dec 31, 2023 | 6.14B | 161.42M | 2.70% |
| Dec 31, 2022 | 5.98B | 781.43M | 15.03% |
| Dec 31, 2021 | 5.20B | -339.42M | -6.13% |
| Dec 31, 2020 | 5.54B | -818.21M | -12.87% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shandong Xinhua Pharmaceutical Company | 9.28B |
| China Traditional Chinese Medicine Holdings Co. | 17.08B |
| Sihuan Pharmaceutical Holdings Group | 2.30B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 763.16M |
| Consun Pharmaceutical Group | 3.58B |
| CanSino Biologics | 1.19B |
| CF PharmTech | 647.51M |
| SSY Group | 4.58B |